{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:50:35Z","timestamp":1791330635990,"version":"4.3.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"DOI":"10.1038\/s41401-026-01943-1","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:01:19Z","timestamp":1791324079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting mitochondrial morphofunctional homeostasis and oxidative stress: Iristectorigenin A protects against cardiac remodeling via SIRT6\/FOXO1 signaling"],"prefix":"10.1038","author":[{"given":"Jia-hao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-xue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-feng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sha-sha","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu-jun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-zhu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"1943_CR1","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118:3272\u201387.","journal-title":"Cardiovasc Res"},{"key":"1943_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40639-6","volume":"14","author":"ZG Ma","year":"2023","unstructured":"Ma ZG, Yuan YP, Fan D, Zhang X, Teng T, Song P, et al. IRX2 regulates angiotensin II-induced cardiac fibrosis by transcriptionally activating EGR1 in male mice. Nat Commun. 2023;14:4967.","journal-title":"Nat Commun"},{"key":"1943_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48970-2","volume":"15","author":"YL Ma","year":"2024","unstructured":"Ma YL, Kong CY, Guo Z, Wang MY, Wang P, Liu FY, et al. Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5\/NR4a1 axis. Nat Commun. 2024;15:4757.","journal-title":"Nat Commun"},{"key":"1943_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300585","volume":"10","author":"YH Bei","year":"2023","unstructured":"Bei YH, Zhu YJ, Wei M, Yin MM, Li L, Chen C, et al. HIPK1 inhibition protects against pathological cardiac hypertrophy by inhibiting the CREB-C\/EBP\u03b2 axis. Adv Sci. 2023;10:e2300585.","journal-title":"Adv Sci"},{"key":"1943_CR5","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIRCULATIONAHA.115.013894","volume":"131","author":"GG Schiattarella","year":"2015","unstructured":"Schiattarella GG, Hill JA. Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload. Circulation. 2015;131:1435\u201347.","journal-title":"Circulation"},{"key":"1943_CR6","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","volume":"144","author":"S Ranjbarvaziri","year":"2021","unstructured":"Ranjbarvaziri S, Kooiker KB, Ellenberger M, Fajardo G, Zhao MM, Vander Roest AS, et al. Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy. Circulation. 2021;144:1714\u201331.","journal-title":"Circulation"},{"key":"1943_CR7","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/CIRCRESAHA.121.318241","volume":"128","author":"GD Lopaschuk","year":"2021","unstructured":"Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED. Cardiac energy metabolism in heart failure. Circ Res. 2021;128:1487\u2013513.","journal-title":"Circ Res"},{"key":"1943_CR8","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.121.055727","volume":"145","author":"LF Zhuang","year":"2022","unstructured":"Zhuang LF, Jia KN, Chen C, Li ZG, Zhao JX, Hu J, et al. DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics. Circulation. 2022;145:829\u201346.","journal-title":"Circulation"},{"key":"1943_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/cvr\/cvp344","volume":"85","author":"H Bugger","year":"2010","unstructured":"Bugger H, Schwarzer M, Chen D, Schrepper A, Amorim PA, Schoepe M, et al. Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovasc Res. 2010;85:376\u201384.","journal-title":"Cardiovasc Res"},{"key":"1943_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.602100","volume":"7","author":"J Wu","year":"2020","unstructured":"Wu J, Lu J, Huang JY, You JY, Ding ZW, Ma LL, et al. Variations in energy metabolism precede alterations in cardiac structure and function in hypertrophic preconditioning. Front Cardiovasc Med. 2020;7:602100.","journal-title":"Front Cardiovasc Med"},{"key":"1943_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.822969","volume":"8","author":"D Yang","year":"2022","unstructured":"Yang D, Liu HQ, Liu FY, Guo Z, An P, Wang MY, et al. Mitochondria in pathological cardiac hypertrophy research and therapy. Front Cardiovasc Med. 2022;8:822969.","journal-title":"Front Cardiovasc Med"},{"key":"1943_CR12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00204-024-03696-4","volume":"98","author":"K Jomova","year":"2024","unstructured":"Jomova K, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M. Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants. Arch Toxicol. 2024;98:1323\u201367.","journal-title":"Arch Toxicol"},{"key":"1943_CR13","doi-asserted-by":"publisher","first-page":"324","DOI":"10.21037\/atm.2017.06.17","volume":"5","author":"D Moris","year":"2017","unstructured":"Moris D, Spartalis M, Tzatzaki E, Spartalis E, Karachaliou GS, Triantafyllis AS, et al. The role of reactive oxygen species in myocardial redox signaling and regulation. Ann Transl Med. 2017;5:324.","journal-title":"Ann Transl Med"},{"key":"1943_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103426","volume":"78","author":"L Pham","year":"2024","unstructured":"Pham L, Arroum T, Wan J, Pavelich L, Bell J, Morse PT, et al. Regulation of mitochondrial oxidative phosphorylation through tight control of cytochrome c oxidase in health and disease - Implications for ischemia\/reperfusion injury, inflammatory diseases, diabetes, and cancer. Redox Biol. 2024;78:103426.","journal-title":"Redox Biol"},{"key":"1943_CR15","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/CIRCRESAHA.121.318988","volume":"131","author":"XQ Wu","year":"2022","unstructured":"Wu XQ, Liu H, Brooks A, Xu SW, Luo JQ, Steiner R, et al. SIRT6 mitigates heart failure with preserved ejection fraction in diabetes. Circ Res. 2022;131:926\u201343.","journal-title":"Circ Res"},{"key":"1943_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107573","volume":"211","author":"PX Wang","year":"2025","unstructured":"Wang PX, Wang LP, Liu C, Hu YH, Feng GD, Lian ZQ, et al. YAP K236 acetylation facilitates its nucleic export and deprived the protection against cardiac hypertrophy in mice. Pharmacol Res. 2025;211:107573.","journal-title":"Pharmacol Res."},{"key":"1943_CR17","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1038\/nm.2961","volume":"18","author":"NR Sundaresan","year":"2012","unstructured":"Sundaresan NR, Vasudevan P, Zhong L, Kim G, Samant S, Parekh V, et al. The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat Med. 2012;18:1643\u201350.","journal-title":"Nat Med"},{"key":"1943_CR18","doi-asserted-by":"publisher","first-page":"7914","DOI":"10.1093\/nar\/gkz528","volume":"47","author":"S Rezazadeh","year":"2019","unstructured":"Rezazadeh S, Yang D, Tombline G, Simon M, Regan SP, Seluanov A, et al. SIRT6 promotes transcription of a subset of NRF2 targets by mono-ADP-ribosylating BAF170. Nucleic Acids Res. 2019;47:7914\u201328.","journal-title":"Nucleic Acids Res"},{"key":"1943_CR19","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/lgbt.2015.0129","volume":"2","author":"W Byne","year":"2015","unstructured":"Byne W. Priorities to address gaps in LGBT health research. LGBT Health. 2015;2:285\u20136.","journal-title":"LGBT Health"},{"key":"1943_CR20","doi-asserted-by":"publisher","first-page":"E493","DOI":"10.1152\/ajpendo.00122.2017","volume":"313","author":"XN Cui","year":"2017","unstructured":"Cui XN, Yao L, Yang XY, Gao Y, Fang FD, Zhang J, et al. SIRT6 regulates metabolic homeostasis in skeletal muscle through activation of AMPK. Am J Physiol Endocrinol Metab. 2017;313:E493\u2013505.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"1943_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112538","volume":"146","author":"SM Wang","year":"2022","unstructured":"Wang SM, Ye LF, Wang LH. Traditional Chinese medicine enhances myocardial metabolism during heart failure. Biomed Pharmacother. 2022;146:112538.","journal-title":"Biomed Pharmacother"},{"key":"1943_CR22","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1016\/j.jacc.2017.04.041","volume":"69","author":"PP Hao","year":"2017","unstructured":"Hao PP, Jiang F, Cheng J, Ma LY, Zhang Y, Zhao YX. Traditional Chinese medicine for cardiovascular disease: evidence and potential mechanisms. J Am Coll Cardiol. 2017;69:2952\u201366.","journal-title":"J Am Coll Cardiol"},{"key":"1943_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3389\/fphar.2016.00469","volume":"7","author":"C Liu","year":"2016","unstructured":"Liu C, Huang Y. Chinese herbal medicine on cardiovascular diseases and the mechanisms of action. Front Pharmacol. 2016;7:469.","journal-title":"Front Pharmacol."},{"key":"1943_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jpba.2014.05.008","volume":"98","author":"GY Xie","year":"2014","unstructured":"Xie GY, Zhu Y, Shu P, Qin XY, Wu G, Wang Q, et al. Phenolic metabolite profiles and antioxidants assay of three Iridaceae medicinal plants for traditional Chinese medicine \u201cShe-gan\u201d by on-line HPLC-DAD coupled with chemiluminescence (CL) and ESI-Q-TOF-MS\/MS. J Pharm Biomed Anal. 2014;98:40\u201351.","journal-title":"J Pharm Biomed Anal"},{"key":"1943_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154252","volume":"104","author":"T Wuniqiemu","year":"2022","unstructured":"Wuniqiemu T, Teng FZ, Qin JJ, Lv YB, Nabijan M, Luo QL, et al. Iristectorigenin A exerts novel protective properties against airway inflammation and mucus hypersecretion in OVA-induced asthmatic mice: Iristectorigenin A ameliorates asthma phenotype. Phytomedicine. 2022;104:154252.","journal-title":"Phytomedicine"},{"key":"1943_CR26","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1038\/s41401-025-01613-8","volume":"46","author":"D Li","year":"2025","unstructured":"Li D, Li JH, Guo YY, Chen YJ, Zhang M, Xu FX, et al. PHB2 protects against pressure overload-induced myocardial remodeling in mice via stabilizing TOMM40 and regulating mitochondrial morphofunctional homeostasis. Acta Pharmacol Sin. 2025;46:3217\u201329.","journal-title":"Acta Pharmacol Sin."},{"key":"1943_CR27","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/CIRCULATIONAHA.123.065603","volume":"149","author":"SY Xie","year":"2024","unstructured":"Xie SY, Liu SQ, Zhang T, Shi WK, Xing Y, Fang WX, et al. USP28 serves as a key suppressor of mitochondrial morphofunctional defects and cardiac dysfunction in the diabetic heart. Circulation. 2024;149:684\u2013706.","journal-title":"Circulation"},{"key":"1943_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157001","volume":"145","author":"YJ Wang","year":"2025","unstructured":"Wang YJ, Chen RS, Dou HQ, Huang JJ, Guo LY, Lu LY, et al. Loganin epigenetically rescues mitochondrial complex III dysfunction via DNMT1-UQCRC1 demethylation to halt cardiac remodeling after myocardial infarction. Phytomedicine. 2025;145:157001.","journal-title":"Phytomedicine"},{"key":"1943_CR29","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1161\/CIRCRESAHA.119.315767","volume":"126","author":"AE Dikalova","year":"2020","unstructured":"Dikalova AE, Pandey A, Xiao L, Arslanbaeva L, Sidorova T, Lopez MG, et al. Mitochondrial deacetylase Sirt3 reduces vascular dysfunction and hypertension while Sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress. Circ Res. 2020;126:439\u201352.","journal-title":"Circ Res"},{"key":"1943_CR30","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00109-010-0663-9","volume":"88","author":"J Ren","year":"2010","unstructured":"Ren J, Pulakat L, Whaley-Connell A, Sowers JR. Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med (Berl). 2010;88:993\u20131001.","journal-title":"J Mol Med (Berl)"},{"key":"1943_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107970","volume":"221","author":"C Cozzolino","year":"2025","unstructured":"Cozzolino C, Floris E, Icolaro F, Pontecorvi V, Bordin A, Frati G, et al. Sirtuin-mediated modulation of cardiac fibrosis: Emerging molecular insights and therapeutic perspectives. Pharmacol Res. 2025;221:107970.","journal-title":"Pharmacol Res."},{"key":"1943_CR32","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1089\/ars.2017.7178","volume":"28","author":"N D\u2019Onofrio","year":"2018","unstructured":"D\u2019Onofrio N, Servillo L, Balestrieri ML. SIRT1 and SIRT6 signaling pathways in cardiovascular disease protection. Antioxid Redox Signal. 2018;28:711\u201332.","journal-title":"Antioxid Redox Signal"},{"key":"1943_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41392-024-01816-1","volume":"9","author":"F Peng","year":"2024","unstructured":"Peng F, Liao MR, Jin WK, Liu W, Li ZX, Fan ZC, et al. 2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis. Signal Transduct Target Ther. 2024;9:133.","journal-title":"Signal Transduct Target Ther"},{"key":"1943_CR34","doi-asserted-by":"publisher","first-page":"23286","DOI":"10.1021\/acs.jafc.4c05945","volume":"72","author":"SY Wen","year":"2024","unstructured":"Wen SY, Ng SC, Chiu YT, Tai PY, Chen TJ, Chen CJ, et al. Enhanced SIRT1 activity by galangin mitigates UVB-induced senescence in dermal fibroblasts via p53 acetylation regulation and activation. J Agric Food Chem. 2024;72:23286\u201394.","journal-title":"J Agric Food Chem"},{"key":"1943_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.157514","volume":"150","author":"CL Hu","year":"2026","unstructured":"Hu CL, Xu T, Xu HL, Pang MJ, Zhang GY, Han X, et al. Ononin promotes bone marrow-derived mesenchymal stem cells survival via SIRT6\/Nrf2 signaling for myocardial infarction repair. Phytomedicine. 2026;150:157514.","journal-title":"Phytomedicine"},{"key":"1943_CR36","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1111\/bph.15899","volume":"179","author":"LB Liu","year":"2022","unstructured":"Liu LB, Huang SH, Qiu HL, Cen XF, Guo YY, Li D, et al. Limonin stabilises sirtuin 6 (SIRT6) by activating ubiquitin specific peptidase 10 (USP10) in cardiac hypertrophy. Br J Pharmacol. 2022;179:4516\u201333.","journal-title":"Br J Pharmacol."},{"key":"1943_CR37","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.molcel.2019.07.023","volume":"75","author":"SM Jung","year":"2019","unstructured":"Jung SM, Hung CM, Hildebrand SR, Sanchez-Gurmaches J, Martinez-Pastor B, Gengatharan JM, et al. Non-canonical mTORC2 signaling regulates brown adipocyte lipid catabolism through SIRT6-FoxO1. Mol Cell. 2019;75:807\u201322.","journal-title":"Mol Cell"},{"key":"1943_CR38","first-page":"58","volume":"8","author":"RH Han","year":"2021","unstructured":"Han RH, Huang HM, Han H, Chen H, Zeng F, Xie X, et al. Propofol postconditioning ameliorates hypoxia\/reoxygenation induced H9c2 cell apoptosis and autophagy via upregulating forkhead transcription factors under hyperglycemia. Mil Med Res. 2021;8:58.","journal-title":"Mil Med Res"},{"key":"1943_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2026.108122","volume":"225","author":"X Wu","year":"2026","unstructured":"Wu X, Du X, Lu CX. Targeting FoxO1 in cardiovascular diseases: Mechanisms and therapeutic potential. Pharmacol Res. 2026;225:108122.","journal-title":"Pharmacol Res."},{"key":"1943_CR40","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.tips.2022.09.010","volume":"43","author":"A Orea-Soufi","year":"2022","unstructured":"Orea-Soufi A, Paik J, Bragan\u00e7a J, Donlon TA, Willcox BJ, Link W. FOXO transcription factors as therapeutic targets in human diseases. Trends Pharmacol Sci. 2022;43:1070\u201384.","journal-title":"Trends Pharmacol Sci."},{"key":"1943_CR41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1056\/NEJMcp2305181","volume":"392","author":"A Cannata","year":"2025","unstructured":"Cannata A, McDonagh TA. Heart failure with preserved ejection fraction. N Engl J Med. 2025;392:173\u201384.","journal-title":"N Engl J Med"},{"key":"1943_CR42","doi-asserted-by":"publisher","first-page":"e1006","DOI":"10.1161\/CIR.0000000000001307","volume":"151","author":"SS Khan","year":"2025","unstructured":"Khan SS, Breathett K, Braun LT, Chow SL, Gupta DK, Lekavich C, et al. Risk-based primary prevention of heart failure: a scientific statement from the American Heart Association. Circulation. 2025;151:e1006\u201326.","journal-title":"Circulation"},{"key":"1943_CR43","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1161\/CIRCRESAHA.122.321050","volume":"131","author":"XD Wang","year":"2022","unstructured":"Wang XD, Zhang GY, Dasgupta S, Niewold EL, Li C, Li QF, et al. ATF4 protects the heart from failure by antagonizing oxidative stress. Circ Res. 2022;131:91\u2013105.","journal-title":"Circ Res"},{"key":"1943_CR44","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/CIRCRESAHA.116.303584","volume":"116","author":"DI Brown","year":"2015","unstructured":"Brown DI, Griendling KK. Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ Res. 2015;116:531\u201349.","journal-title":"Circ Res"},{"key":"1943_CR45","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ejhf.1320","volume":"21","author":"A van der Pol","year":"2019","unstructured":"van der Pol A, van Gilst WH, Voors AA, van der Meer P. Treating oxidative stress in heart failure: past, present and future. Eur J Heart Fail. 2019;21:425\u201335.","journal-title":"Eur J Heart Fail"},{"key":"1943_CR46","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","volume":"7","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Wang L, Wang SQ, Cheng HX, Xu L, Pei GQ, et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther. 2022;7:78.","journal-title":"Signal Transduct Target Ther"},{"key":"1943_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2021.153918","volume":"98","author":"M Li","year":"2022","unstructured":"Li M, Han B, Zhao H, Xu CY, Xu DK, Sieniawska E, et al. Biological active ingredients of Astragali Radix and its mechanisms in treating cardiovascular and cerebrovascular diseases. Phytomedicine. 2022;98:153918.","journal-title":"Phytomedicine"},{"key":"1943_CR48","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cell.2020.02.051","volume":"181","author":"OM Russell","year":"2020","unstructured":"Russell OM, Gorman GS, Lightowlers RN, Turnbull DM. Mitochondrial diseases: hope for the future. Cell. 2020;181:168\u201388.","journal-title":"Cell"},{"key":"1943_CR49","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3390\/antiox11040635","volume":"11","author":"MM Ogle","year":"2022","unstructured":"Ogle MM, Rolando Trevino J, Schell J, Varmazyad M, Horikoshi N, Gius D. Manganese superoxide dismutase acetylation and regulation of protein structure in breast cancer biology and therapy. Antioxidants. 2022;11:635.","journal-title":"Antioxidants"},{"key":"1943_CR50","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/s41569-023-00887-x","volume":"20","author":"J Ritterhoff","year":"2023","unstructured":"Ritterhoff J, Tian R. Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges. Nat Rev Cardiol. 2023;20:812\u201329.","journal-title":"Nat Rev Cardiol"},{"key":"1943_CR51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.yjmcc.2016.01.023","volume":"92","author":"S Veeranki","year":"2016","unstructured":"Veeranki S, Givvimani S, Kundu S, Metreveli N, Pushpakumar S, Tyagi SC. Moderate intensity exercise prevents diabetic cardiomyopathy associated contractile dysfunction through restoration of mitochondrial function and connexin 43 levels in db\/db mice. J Mol Cell Cardiol. 2016;92:163\u201373.","journal-title":"J Mol Cell Cardiol"},{"key":"1943_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103745","volume":"85","author":"RJ Li","year":"2025","unstructured":"Li RJ, Gao F, Chen YN, Zhao JM, Shi R, Li M, et al. USP10 protects against pressure overload-induced mitochondrial morphofunctional defects and pathological cardiac hypertrophy through stabilizing cytoplasmic Mfn2. Redox Biol. 2025;85:103745.","journal-title":"Redox Biol"},{"key":"1943_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113932","volume":"146","author":"C Cheng","year":"2025","unstructured":"Cheng C, Wang Y, Huo J, Zhang YF, Li RL. SIRT6 knockdown alleviates keratinocyte hyperproliferation and inflammation in psoriasis via modulating acetylation of FOXO1. Int Immunopharmacol. 2025;146:113932.","journal-title":"Int Immunopharmacol"},{"key":"1943_CR54","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCRESAHA.111.246488","volume":"110","author":"MF Oellerich","year":"2012","unstructured":"Oellerich MF, Potente M. FOXOs and sirtuins in vascular growth, maintenance, and aging. Circ Res. 2012;110:1238\u201351.","journal-title":"Circ Res"},{"key":"1943_CR55","doi-asserted-by":"publisher","first-page":"10042","DOI":"10.1073\/pnas.0400593101","volume":"101","author":"H Daitoku","year":"2004","unstructured":"Daitoku H, Hatta M, Matsuzaki H, Aratani S, Ohshima T, Miyagishi M, et al. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci USA. 2004;101:10042\u20137.","journal-title":"Proc Natl Acad Sci USA."}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01943-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01943-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01943-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:02:43Z","timestamp":1791327763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01943-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":55,"alternative-id":["1943"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01943-1","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"2 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}